Paper19784739
Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis.
Matsuda Y and 1 other. Med Mol Morphol, 2009. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis. Papers, record 19784739. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19784739
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| DNA Damage | Major topic |
| DNA Repair | Major topic |
| Liver Neoplasms | Major topic |
| Trans-Activators | Major topic |
| Centrosome | |
| Humans | |
| Mitogen-Activated Protein Kinases | |
| Tumor Suppressor Protein p53 | |
| Viral Regulatory and Accessory Proteins |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15542843 | Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-alpha expression. | Mol Cell Biol | 2004 | https://conductscience.org/library/papers/15542843 | PubMed |
| 2 | 18083266 | Temporal treatment with interferon-beta prevents hepatocellular carcinoma in hepatitis B virus X gene transgenic mice. | J Hepatol | 2008 | https://conductscience.org/library/papers/18083266 | PubMed |
| 3 | 12175906 | Increased chromosomal alterations and micronuclei formation in human hepatoma HepG2 cells transfected with the hepatitis B virus HBX gene. | Mutat Res | 2002 | https://conductscience.org/library/papers/12175906 | PubMed |
| 4 | 2034275 | HBx gene of hepatitis B virus induces liver cancer in transgenic mice. | Nature | 1991 | https://conductscience.org/library/papers/2034275 | PubMed |
| 5 | 7815490 | Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. | J Virol | 1995 | https://conductscience.org/library/papers/7815490 | PubMed |
| 6 | 10856831 | Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis. | Mutat Res | 2000 | https://conductscience.org/library/papers/10856831 | PubMed |
| 7 | 11002243 | Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53. | J Med Virol | 2000 | https://conductscience.org/library/papers/11002243 | PubMed |
| 8 | 11244501 | Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis. | Oncogene | 2001 | https://conductscience.org/library/papers/11244501 | PubMed |
| 9 | 9420223 | Hepatitis B virus X protein interferes with cellular DNA repair. | J Virol | 1998 | https://conductscience.org/library/papers/9420223 | PubMed |
| 10 | 1552940 | Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. | Nature | 1992 | https://conductscience.org/library/papers/1552940 | PubMed |
| 11 | 16982752 | HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. | Cancer Res | 2006 | https://conductscience.org/library/papers/16982752 | PubMed |
| 12 | 9837906 | Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9837906 | PubMed |
| 13 | 12829810 | Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication. | J Virol | 2003 | https://conductscience.org/library/papers/12829810 | PubMed |
| 14 | 9039259 | p53, the cellular gatekeeper for growth and division. | Cell | 1997 | https://conductscience.org/library/papers/9039259 | PubMed |
| 15 | 2154703 | Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. | Nature | 1990 | https://conductscience.org/library/papers/2154703 | PubMed |
| 16 | 12208955 | Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes. | J Virol | 2002 | https://conductscience.org/library/papers/12208955 | PubMed |
| 17 | 7828586 | Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. | EMBO J | 1995 | https://conductscience.org/library/papers/7828586 | PubMed |
| 18 | 11461911 | Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11461911 | PubMed |
| 19 | 11686474 | Hepatitis B virus X protein: a multifunctional viral regulator. | J Gastroenterol | 2001 | https://conductscience.org/library/papers/11686474 | PubMed |
| 20 | 10842185 | Hepatitis B viral transactivator HBx alleviates p53-mediated repression of alpha-fetoprotein gene expression. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10842185 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42357668 | Targeted Protein Degradation Strategies in DNA Virus Research. | Viruses | 2026 | https://conductscience.org/library/papers/42357668 | PubMed |
| 35122182 | Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair system. | Mol Biomed | 2022 | https://conductscience.org/library/papers/35122182 | PubMed |
| 34745965 | Autophagy Modulation by Viral Infections Influences Tumor Development. | Front Oncol | 2021 | https://conductscience.org/library/papers/34745965 | PubMed |
| 34366625 | Viral hepatitis: Milestones, unresolved issues, and future goals. | World J Gastroenterol | 2021 | https://conductscience.org/library/papers/34366625 | PubMed |
| 33794968 | HBP1-mediated transcriptional repression of AFP inhibits hepatoma progression. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33794968 | PubMed |
| 33440726 | Tampering of Viruses and Bacteria with Host DNA Repair: Implications for Cellular Transformation. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33440726 | PubMed |
| 32628668 | PD-L1 upregulation by IFN-α/γ-mediated Stat1 suppresses anti-HBV T cell response. | PLoS One | 2020 | https://conductscience.org/library/papers/32628668 | PubMed |
| 31947702 | Chronic Hepatitis B Virus Infection Associated with Increased Colorectal Cancer Risk in Taiwanese Population. | Viruses | 2020 | https://conductscience.org/library/papers/31947702 | PubMed |
| 31698767 | Replenishment of Hepatitis B Virus cccDNA Pool Is Restricted by Baseline Expression of Host Restriction Factors In Vitro. | Microorganisms | 2019 | https://conductscience.org/library/papers/31698767 | PubMed |
| 31683589 | ATM and ATR Expression Potentiates HBV Replication and Contributes to Reactivation of HBV Infection upon DNA Damage. | Viruses | 2019 | https://conductscience.org/library/papers/31683589 | PubMed |
| 30074148 | Hepatitis B Virus X Protein Upregulates Intracellular Calcium Signaling by Binding C-terminal of Orail Protein. | Curr Med Sci | 2018 | https://conductscience.org/library/papers/30074148 | PubMed |
| 29956780 | HBx gene transfection affects the cycle of primary renal tubular epithelial cells through regulating cyclin expression. | Mol Med Rep | 2018 | https://conductscience.org/library/papers/29956780 | PubMed |
| 29435900 | Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis. | J Gastrointest Surg | 2018 | https://conductscience.org/library/papers/29435900 | PubMed |
| 28728568 | Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study. | Chin J Cancer | 2017 | https://conductscience.org/library/papers/28728568 | PubMed |
| 28566884 | Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B. | World J Gastroenterol | 2017 | https://conductscience.org/library/papers/28566884 | PubMed |
| 28348484 | Integrated analysis of microRNA and mRNA expression profiles in HBx-expressing hepatic cells. | World J Gastroenterol | 2017 | https://conductscience.org/library/papers/28348484 | PubMed |
| 27508172 | Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma. | J Hepatocell Carcinoma | 2014 | https://conductscience.org/library/papers/27508172 | PubMed |
| 27420729 | HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway. | Cancer Sci | 2016 | https://conductscience.org/library/papers/27420729 | PubMed |
| 27284442 | HBV X gene point mutations are associated with the risk of hepatocellular carcinoma: A systematic review and meta-analysis. | Mol Clin Oncol | 2016 | https://conductscience.org/library/papers/27284442 | PubMed |
| 26595522 | HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3. | Oncotarget | 2016 | https://conductscience.org/library/papers/26595522 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| ATR | 545 | PubTator's text mining | https://conductscience.org/library/genes/545 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| MAPK8 | 5599 | PubTator's text mining | https://conductscience.org/library/genes/5599 | NCBI Gene |
| MAPK9 | 5601 | PubTator's text mining | https://conductscience.org/library/genes/5601 | NCBI Gene |
| PTK2B | 2185 | PubTator's text mining | https://conductscience.org/library/genes/2185 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| ZHX2 | 22882 | PubTator's text mining | https://conductscience.org/library/genes/22882 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19784739
GET https://conductscience.org/api/papers/v1/19784739/references?page=2